Mikami H, Ogasawara M, Matsubara Y, Kikuchi M, Miyabayashi S, Kure S, Narisawa K
Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.
J Hum Genet. 1999;44(1):35-9. doi: 10.1007/s100380050103.
Genetic defects in the methylmalonyl-CoA mutase (MCM) gene cause methylmalonic acidemia (MMA). Only three mutations have been reported among Oriental patients to date. We studied fibroblast cell lines established from three Japanese patients with MCM deficiency. Enzymatic study showed that these patients had the muttype of MMA. Nucleotide sequencing of MCM cDNAs identified three missense mutations: a T to A change at nucleotide position 2082, which results in an amino acid substitution of Glu669 for valine (V669E); a T to A change at position 1179 with the corresponding amino acid substitution of Asp368 for valine (V368D); and a G to A change at position 1182 with the corresponding amino acid substitution of His369 for arginine (R369H). Each of the three missense mutations abolished MCM activity according to a transient expression study. Alignment of these mutations with a recently reported homology model of human MCM allowed us to speculate on the effect of these nonconservative amino acid substitutions on MCM activity: V368D and R369H affected residues in the beta/alpha-(TIM-) barrel domain, on one of the two alpha-helices that form the dimer interface, while V669E altered a residue in the adenosylcobalamin-binding domain in the C terminus.
甲基丙二酰辅酶A变位酶(MCM)基因的遗传缺陷会导致甲基丙二酸血症(MMA)。迄今为止,在东方患者中仅报道了三种突变。我们研究了从三名患有MCM缺陷的日本患者身上建立的成纤维细胞系。酶学研究表明,这些患者患有mut型MMA。对MCM cDNA进行核苷酸测序,鉴定出三个错义突变:核苷酸位置2082处的T到A变化,导致氨基酸Glu669被缬氨酸取代(V669E);位置1179处的T到A变化,相应的氨基酸Asp368被缬氨酸取代(V368D);以及位置1182处的G到A变化,相应的氨基酸His369被精氨酸取代(R369H)。根据瞬时表达研究,这三个错义突变中的每一个都消除了MCM活性。将这些突变与最近报道的人类MCM同源模型进行比对,使我们能够推测这些非保守氨基酸取代对MCM活性的影响:V368D和R369H影响β/α-(TIM-)桶状结构域中的残基,该结构域位于形成二聚体界面的两个α-螺旋之一上,而V669E改变了C末端腺苷钴胺素结合结构域中的一个残基。